Beam Therapeutics Inc (BEAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 207,300 | 152,100 | 187,400 | 85,100 | 195,100 |
| Receivables | 1,114,000 | 1,219,800 | 1,114,900 | 787,800 | 1,051,000 |
| Inventories | 1,665,400 | 1,115,800 | 1,130,600 | 915,700 | 1,049,400 |
| Other current assets | 320,900 | 317,100 | 313,600 | 853,300 | 262,900 |
| TOTAL | $3,307,600 | $2,804,800 | $2,746,500 | $2,641,900 | $2,558,400 |
| Non-Current Assets | |||||
| PPE Net | 1,691,400 | 1,382,000 | 1,379,700 | 1,219,500 | 1,322,100 |
| Investments And Advances | 1,375,200 | 0 | 0 | 137,800 | 0 |
| Intangibles | 6,473,400 | 3,340,600 | 3,346,000 | 3,237,200 | 3,358,500 |
| Other Non-Current Assets | 301,000 | 455,100 | 504,300 | 647,200 | 481,200 |
| TOTAL | $9,841,000 | $5,177,700 | $5,230,000 | $5,241,700 | $5,161,800 |
| Total Assets | $13,148,600 | $7,982,500 | $7,976,500 | $7,883,600 | $7,720,200 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 200 | 300 | 300 | 400 | 200,400 |
| Accounts payable and accrued liabilities | 743,900 | 380,600 | 373,400 | 271,200 | 350,400 |
| Accrued Expenses | 709,200 | 702,600 | 589,900 | 588,900 | 810,700 |
| Other current liabilities | N/A | N/A | N/A | 7,200 | N/A |
| TOTAL | $2,250,500 | $1,861,300 | $1,984,700 | $2,036,000 | $2,205,300 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,389,300 | 1,238,400 | 1,237,400 | 1,239,500 | 1,241,000 |
| Other Non-Current Liabilities | 911,600 | 1,241,300 | 1,261,000 | 885,600 | 1,239,300 |
| TOTAL | $7,377,500 | $2,612,500 | $2,637,900 | $2,716,900 | $2,633,300 |
| Total Liabilities | $9,628,000 | $4,473,800 | $4,622,600 | $4,752,900 | $4,838,600 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 146,112 | 145,979 | 145,447 | 144,886 | 144,153 |
| Common Shares | 717,400 | 717,400 | 717,400 | 717,400 | 717,400 |
| Retained earnings | 5,761,900 | 5,782,900 | 5,630,800 | 5,447,200 | 5,293,100 |
| Other shareholders' equity | -9,900 | -26,500 | 7,400 | 13,300 | -96,200 |
| TOTAL | $3,520,600 | $3,508,700 | $3,353,900 | $3,130,700 | $2,881,600 |
| Total Liabilities And Equity | $13,148,600 | $7,982,500 | $7,976,500 | $7,883,600 | $7,720,200 |